<International Circulation>: Guidelines from different regions have different recommendations for the application of fondaparinux in patients with ACS undergoing PCI. What is your view of this situation?

 《国际循环》：不同地区的指南对接受PCI治疗的ACS患者中磺达肝癸钠应用的推荐不同。您对此有何看法？

    Prof. Jolly: You are correct. The European guidelines gave a stronger endorsement in patients who are undergoing an early invasive strategy than the American guidelines. I think this represents the uncertainty around what heparin dose to use and how to treat these patients. We now have much more clear information regarding this and perhaps the guidelines will change.

    Jolly教授：你说的对。在接受早期侵入性策略治疗的患者中，欧洲指南较美国指南给予了更强的支持。我认为这代表着应用何种肝素剂量以及如何治疗这些患者的不确定性。就此我们现在有了更为明确的信息，指南可能将会改变。